150
Participants
Start Date
December 31, 2002
Study Completion Date
July 31, 2003
Sandostatin LAR Depot
North Shore Hematology Oncology, East Setauket
Consultants in Medical Oncology-Hematology, Drexel Hill
Regional Hematology Oncology Assoc, Langhorne
Oncology & Hematology Associates of SW VA, Roanoke
Raleigh Hematology Oncology Associates, Wake Practice, Raleigh
Mid-Florida Hematology & Oncology Centers, PA, Orange City
Oncology Hematology Group of South Florida, Miami
Oncology & Hematology Associates of West Broward, Tamarac
Pasco Hernando Oncology Associates, New Port Richey
Jones Oncolgy/Hematology Clinic, Germantown
Delta Oncology, Greenwood
Lawrence M. Stallings, MD, Wooster
Nashat Y. Gabrail, MD, Canton
North Coast Cancer Care, Inc., Sandusky
Suniti Medical Corporation, Merrillville
Cancer Care Center, Bloomington
Genesys Hurley Cancer Institute, Flint
Cancer & Hematology Centers of Western Michigan, Grand Rapids
Oncology Services of Aberdeen, Borden
Dakota Clinic/Odyssey Research Services, Fargo
Creticos Cancer Center, Chicago
Decatur Memorial Hospital, Decatur
Arch Medical Services/The Center for Cancer Care and Research, St Louis
Heartland Hematology Oncology Associates, Kansas City
Missouri Cancer Associates, Columbia
Scott & White Hospital/CCPC, Waco
McFaddin Ward Cancer - TOPA, Beaumont
New Mexico Cancer Care Associates, Santa Fe
Kenmar Research Institute, Los Angeles
Pacific Shores Medical Center, Long Beach
Kenmar Research Institute, Burbank
Compassionate Cancer Care medical Group, Inc., Fountain Valley
Bay Area Cancer Research Group, Concord
California Cancer Care, Inc., Greenbrae
Lead Sponsor
Quintiles, Inc.
INDUSTRY
Novartis Pharmaceuticals
INDUSTRY